课题基金 / 基金详情

Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial

Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
重复剂量行为干预减少阿片类药物过量:一项两中心随机对照疗效试验
批准号:
9896799
负责人:
PHILLIP O COFFIN
金额:
$83.16万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-15 至 2023-03-31

项目摘要

项目成果

PHILLIP O COFFIN的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
Project Summary/Abstract The United States is amidst an epidemic of opioid overdose, including opioid analgesics, heroin, and illicitly- manufactured fentanyl and related synthetic opioids. Multiple interventions to address opioid overdose have been employed, such as lay access to naloxone to reverse opioid overdose, yet the number of people dying each year from opioid overdose continues to increase each year. In addition to efforts to reduce mortality, efforts are needed to reduce the occurrence of any opioid overdose, particularly given the rapidity of synthetic opioid overdoses, which may restrict the time available to intervene once an overdose occurs. Opioid stewardship activities, necessary to avert yet another generation affected by the opioid epidemic, may paradoxically contribute to the illicit opioid epidemic, and expanded access to opioid use disorder treatment, while essential, is limited by resources, stigma, and the willingness of patients to accept the intervention. The NIDA-funded pilot study of REBOOT (repeated dose behavioral intervention to reduce opioid overdose), a motivational interviewing-based brief intervention addressing experienced and witnessed overdose events, resulted in substantial reductions in the occurrence of any opioid overdose, as well as the number of opioid overdoses that occurred during 16 months of follow-up. This full trial of REBOOT includes two regions of the United States – San Francisco, largely unaffected by the fentanyl epidemic – and Boston, at the epicenter of fentanyl use, overdose, and mortality. REBOOT will enroll 300 persons with opioid use disorder who are currently using opioids, have previously received take-home naloxone, and are at high-risk for recurrent overdose. Participants will be randomized to the intervention or attention-control and seen every four months for 16 months, with interval assessments for overdose events, overdose risk factors, engagement in substance use disorder treatment, and substance use. Medical records will be reviewed to capture unreported overdose events, including death. Results will determine if addressing overdose through motivational interviewing can reduce the occurrence of overdose, contributing to efforts to respond to this national emergency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Midcareer K24 Award for Mentoring and Patient-Oriented Research
Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
PRIME: PrEP Intervention for people who Inject MEthamphetamine
海外基金